1344955-38-9 Usage
Uses
Used in Pharmaceutical Synthesis:
(R)-1-(3-fluoro-4-methylphenyl)ethanol is used as a building block for the synthesis of pharmaceuticals. Its unique molecular structure and functional groups make it a versatile and useful intermediate in the development of various medications.
Used in Agrochemical Production:
In the agrochemical industry, (R)-1-(3-fluoro-4-methylphenyl)ethanol is utilized as a key component in the creation of different agrochemicals. Its specific properties contribute to the effectiveness of these products in agricultural applications.
Used in Fine Chemicals Synthesis:
(R)-1-(3-fluoro-4-methylphenyl)ethanol is also employed as an intermediate in the synthesis of fine chemicals. Its fluorinated and methylated phenyl group impart specific properties that are valuable in various industrial applications, making it a sought-after compound in this field.
Check Digit Verification of cas no
The CAS Registry Mumber 1344955-38-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,4,4,9,5 and 5 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1344955-38:
(9*1)+(8*3)+(7*4)+(6*4)+(5*9)+(4*5)+(3*5)+(2*3)+(1*8)=179
179 % 10 = 9
So 1344955-38-9 is a valid CAS Registry Number.
1344955-38-9Relevant academic research and scientific papers
PYRAZOLE DERIVATIVES AS BROMODOMAIN INHIBITORS
-
Page/Page column 83, (2018/09/21)
The present invention is directed to pyrazole derivatives, pharmaceutical compositions comprising the compounds and the use of the compounds or the compositions in the treatment of various diseases
Preparative access to medicinal chemistry related chiral alcohols using carbonyl reductase technology
Rowan, Andrew S.,Moody, Thomas S.,Howard, Roger M.,Underwood, Toby J.,Miskelly, Iain R.,He, Yanan,Wang, Bo
, p. 1369 - 1381 (2013/12/04)
Libraries of highly enantioenriched secondary alcohols in both enantiomeric forms were synthesised by enzymatic reduction of their parent ketones using selectAZyme carbonyl reductase (CRED) technology. Commercially available CREDs were able to reduce a range of substrate classes efficiently and with very high enantioselectivity. Matching substrate classes to small subsets of CREDs enabled the fast development of preparative bioreductions and the rapid generation of 100-1500 mg samples of chiral alcohols in typically >95% ee and the majority in ≥99.0% ee. The conditions for small scale synthesis were then scaled up to 0.5 kg to deliver one of the chiral alcohols, (S)-1-(4-bromophenyl)-2-chloroethanol, in 99.8% ee and 91% isolated yield.
